UCLA Hematology/Oncology - Westlake is a clinical research site located in Westlake Village, California, United States 91361.
Crixeo Health Trust Score: 67/100 (FAIR). This profile has not yet been claimed by the site owner.
UCLA Hematology/Oncology - Westlake has participated in 5 clinical trials with 4 currently active.
Therapeutic areas: HER2 Positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
Sponsors: Seagen, a wholly owned subsidiary of Pfizer, Pfizer.
Trust Score: 67/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
UCLA Hematology/Oncology - Westlake has a Crixeo Trust Score of 67/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
UCLA Hematology/Oncology - Westlake has 5 clinical trials on record, with 4 currently active. Their work covers HER2 Positive Breast Cancer, Urothelial Carcinoma, Metastatic Castration Sensitive Prostate Cancer (mCSPC).
UCLA Hematology/Oncology - Westlake has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.